Your browser doesn't support javascript.
loading
Diruthenium(ii,iii) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells.
Alves Rico, Samara R; Abbasi, Azhar Z; Ribeiro, Geise; Ahmed, Taksim; Wu, Xiao Yu; de Oliveira Silva, Denise.
Affiliation
  • Alves Rico SR; Laboratory for Synthetic and Structural Inorganic Chemistry - Bioinorganic and Metallodrugs, Department of Fundamental Chemistry, Institute of Chemistry, University of São Paulo, Av. Prof. Lineu Prestes, 748, B2 T, 05508-000, São Paulo, SP, Brazil. deosilva@iq.usp.br.
Nanoscale ; 9(30): 10701-10714, 2017 Aug 03.
Article in En | MEDLINE | ID: mdl-28678269
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Drug Carriers / Ibuprofen / Naproxen / Nanoparticles / Lipids Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Nanoscale Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Drug Carriers / Ibuprofen / Naproxen / Nanoparticles / Lipids Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: Nanoscale Year: 2017 Document type: Article Affiliation country: